Vir Biotechnology (VIR) Pension (2019 - 2020)
Vir Biotechnology (VIR) reported Pension of $2.9 million for Q4 2020, up 52.63% on a YoY basis from $1.9 million in Q1 2020, and up 52.63% sequentially from $1.9 million in Q4 2019.
Vir Biotechnology (VIR) Pension (2019 - 2020) Analysis & Trends
Vir Biotechnology (VIR) has 2 years of Pension data on file, last reported at $2.9 million in Q4 2020.
- For the quarter ending Q4 2020, Pension rose 52.63% year-over-year to $2.9 million; the trailing twelve-month figure through Dec 2020 stood at $2.9 million (up 52.63% YoY), and the FY2020 full-year result was $2.9 million, up 52.63% from the prior year.
- Pension improved to $2.9 million in Q4 2020, from $1.9 million in the prior quarter.
- In the past five years, Pension ranged from a high of $2.9 million in Q4 2020 to a low of $1.9 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.90 Mn |
| Dec 31, 2019 | 1.90 Mn |